FTRE: Fortrea Holdings Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 1,400.22
Enterprise Value ($M) 2,420.12
Book Value ($M) 1,513.50
Book Value / Share 16.87
Price / Book 0.93
NCAV ($M) -1,213.30
NCAV / Share -13.53
Price / NCAV -1.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.11
Return on Assets (ROA) -0.07
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 1.18
Current Ratio 1.18

Balance Sheet (mrq) ($M)
Current Assets 936.90
Assets 3,663.70
Liabilities 2,150.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-07 13G/A BlackRock, Inc.
02-07 13G/A Fmr Llc
01-31 13D/A Starboard Value LP
11-14 13G Beck Mack & Oliver Llc
2024-02-14 13G Sessa Capital (Master), L.P. 7.18
2024-02-13 13G/A Vanguard Group Inc 11.20 -1.08

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 153,877 731,469 21.04
2025-02-20 162,785 578,733 28.13
2025-02-19 199,244 612,371 32.54
2025-02-18 148,957 675,624 22.05

(click for more detail)

Similar Companies
GH – Guardant Health, Inc. NTRA – Natera, Inc.


Financial data and stock pages provided by
Fintel.io